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INTRODUCTION
Hepatic encephalopathy (HE) is present in upto 70% of
all patients with cirrhosis, including patients with
abnormalities demonstrable only by psychometric
testing.1,2 It accompanies portal-systemic shunting of
venous blood that occurs either spontaneously, due to
portal hypertension, or surgically following porto-caval
anastomosis surgery or trans-jugular intra-hepatic
porto-systemic stent shunt (TIPS) aimed at relieving
portal hypertension. Patients with HE characteristically
present with the development of acute encephalopathy
with an abrupt decline in the level of consciousness,
often manifested as confusion or coma. A precipitating
factor can be usually identified, and the treatment of the
episode is directed towards the correction of this
precipitant. Once the precipitating condition has been
resolved, the encephalopathy also subsides usually.3
The most common precipitant identified is gastro-
intestinal bleeding,4 which is responsible for upto 34%
cases of HE.5 Gastrointestinal bleeding contributes
approximately 20 grams of proteins per 100 ml of blood,5
leading to an increased production of nitrogenous
products especially ammonia from the gut. Other
precipitants include constipation, excessive dietary
protein, especially animal protein hypovolemia, shock,
hypokalemia and alkalosis.6,7 Use of medications acting
on the CNS such as opiates and benzodiazepine,
presence of infections and shunt procedures have also
been implicated in the precipitation of HE.8-10
Neurological deficits in patients with HE secondary to a
precipitating event are usually completely reversible
following correction of the cause, and these patients
have a good prognosis.3 However, it is imperative that
such precipitating events are identified earlier, and
patients’ attendants counseled regarding their identi-
fication to ensure that medical care is provided promptly,
and thus subsequently ensuring better patient outcomes.
The aims of this study were to evaluate the precipitant
factors of hepatic encephalopathy and their impact on
hospital stay and mortality.
METHODOLOGY
A hospital based cross-sectional study of patients
presenting to The Aga Khan University Hospital,
Karachi, between January 2005 and December 2007
with hepatic encephalopathy was carried out. All
patients with liver disease who were diagnosed as
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having acute HE secondary to liver cirrhosis and portal
hypertension and classified as type C HE according to
the working party classification of HE by Fereci et al.11
were included. The diagnosis of acute HE being made
on the basis of a detailed history and physical
examination, West Haven criteria and Number
Connection Test (NCT). Patients classified as type A HE
(acute liver failure) and type B HE (secondary to portal
systemic bypass without intrinsic hepatocellular
disease)11 were excluded. Also excluded were patients
with concomitant uremic, cerebral, septic, and anoxic
encephalopathy. Renal impairment was defined as
serum creatinine level ≥ 2 mg/dl on admission and
treated with intravenous fluids and albumin whenever
indicated. Liver cirrhosis was diagnosed on the basis of
clinical, biochemical and ultrasonological examination.
Data related to present and past medical history at the
time of admission was collected from the medical
records. The clinical findings on examination including
presence of jaundice, pallor, fever, asterixis, and ascites
were recorded. Demographics and laboratory para-
meters (complete blood count, liver function tests, renal
function tests, serum albumin levels, coagulation profile,
urine analysis, and blood cultures) were collected. The
findings of abdominal ultrasound including liver and
spleen size, parenchymal echogenicity, portal vein
diameter, and ascites was noted in the questionnaire.
An ascitic tap was performed in all patients with ascites
and sent for detailed report and culture in order to
diagnose spontaneous bacterial peritonitis. Urine
detailed report and culture was also sent in all patients,
along with blood culture in order to diagnose any
infection. A chest X-ray was also performed in all patients
on arrival in Emergency Department. 
Patients were classified according to the Child Turcotte
Pugh (CTP) criteria and etiology of cirrhosis and grade
of hepatic encephalopathy on admission was noted.
Grading of hepatic encephalopathy was performed
according to the West Haven Criteria.11 All the patients
were assessed with these criteria and the Number
Connection Tests-A (NCT-A) on daily basis for noting an
improvement/deterioration in HE grade.  Improvement of
HE was defined as complete reversal of clinical
symptoms on the basis of the West Haven criteria and
NCT-A. Patients with HE of ≥ grade 1 on discharge were
considered as ‘did not show improvement’.
All patients underwent standard management during
their hospital stay which included use of ammonia
lowering and gut cleansing agents such as lactulose and
metronidazole, along with dietary protein restriction to
60 gms/day until HE improved. Placement of a
nasogastric tube for feeding was considered in all
patients with HE grade > 2. Proton pump inhibitors,
vitamin K and fresh frozen plasma were used in patients
with upper gastrointestinal bleeding and deranged
coagulation. Patients who presented with upper gastro-
intestinal bleeding subsequently underwent an upper
gastrointestinal endoscopy upon improvement of HE or
earlier in cases of continuing bleeding.
The outcomes assessed were the hospital stay and
death during the hospital admission. 
Statistical analysis was performed using the Statistical
Package for Social Science (SPSS) [15.0, standard
version, copyright © SPSS; 1989-02]. Descriptive
analysis of patients with hepatic encephalopathy was
performed for demographic and laboratory parameters
and results presented as mean ± standard deviation for
quantitative variables. Length of duration of hospital stay
was divided into two categories; less than 4 days and
more than and equal to 4 days and compared with
number of precipitating factors, child’s Pugh class and
grades of encephalopathy using χ2 test for categorical
variables. Relationship of number of precipitating factors
was categorized into 2 categories; one precipitating
factor, and more than and equal to 2 precipitating factors
and compared it with different parameters using χ2
chi-square test. All p-values were two sided and
considered as statistically significant if < 0.05.
RESULTS
A total of 404 patients of cirrhosis with HE were studied,
of whom 252 (62%) were males. Mean age was 55 ± 9
years; other demographic and laboratory parameters
are shown in Table I. There were 291 (72%) patients
with cirrhosis due to hepatitis C infection, while 32 (8%)
had hepatitis B, non-B, non-C cirrhosis was seen in 73
(18%) patients. Hepatitis B and D related cirrhosis was
noted in 7 (1.7%) patients while one patient (0.3%) had
hepatitis B, C and D infections simultaneously. 
Three hundred and seventeen (78%) patients had CTP
class C cirrhosis, while 76 (19%) and 11 (3%) patients
had CTP class B and A cirrhosis respectively. Seventy
(17%) patients were in grade 1 hepatic encephalopathy,
while 178 (44%) had grade 2, 118 (29%) grade 3 and 38
(10%) had grade 4 HE on presentation based on the
West Haven criteria and NCT-A. The common comorbid
conditions present were Diabetes mellitus in 165 (41%),
hypertension in 67 (17%) and ischemic heart disease in
28 (7%).
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Table I: Demographics and laboratory parameters of all patients with
hepatic encephalopathy.
Variables Mean ± Standard Deviation
Age (years) 55 ± 9
Hemoglobin (g/dl) 11.0 ± 2.0
WBC count (x109/l) 9.1 ± 5.4
Platelet count (x109/l) 109.5 ± 60.8
Total bilirubin (mg/dl) 4.3 ± 5.3
Albumin (g/l) 2.3 ± 0.5
Prothrombin time (seconds) 21.4 ± 6.4
Sodium (mEq/l) 132 ± 7.3
Potassium (mEq/l) 4.2 ± 0.8
Creatinine (mg/dl) 1.6 ± 1.6
Different precipitants of HE were identified in 354/404
(88%) patients while none could be found in 50 (12%)
patients. The most common precipitant identified was
spontaneous bacterial peritonitis (SBP) which was seen
in 83 (20.5%) patients. Constipation in 74 (18.3%),
urinary tract infections in 62 (15.3%) and upper
gastrointestinal bleeding in 55 (13.6%) patients were the
other precipitating factors identified. Electrolyte abnor-
mality including hypokalemia were seen in 26 (6.4%)
while hyponatremia was present in 12 (3%) patients.
Acute HE secondary to benzodiazepine use such as
midazolam was noted in 3 patients. Two hundred and
fourteen (53%) patients had one identifiable precipitant,
while 122 (30%) patients had 2 and 18 (5%) patients
had three precipitating factors respectively at the time of
presentation.
Mean hospital stay was 4 ± 3 days; the duration of
hospital stay of 210 (52%) patients was < 4 days, of
which 110 patients (55%) were found out to have only
one precipitating factor. There were 194 patients (48%)
who had a mean stay of > 4 days, out of which 85 (44%)
had ≥ 2 precipitating factors contributing to development
of HE (p < 0.05). Forty (80%) patients, without any
identifiable precipitants had a stay of < 4 days (Table II).
Out of the 210 patients with a hospital stay of < 4 days,
142/210 (67%) had grade 1 or 2 HE on presentation,
while 88/194 patients (45%) with a stay of > 4 days had
stages 3 or 4 HE respectively on presentation (p-value
< 0.05). Additionally advanced grades of HE were noted
in patients with ≥ 2 precipitants on presentation (p < 0.01). 
Improvement of HE defined as complete reversal of
clinical symptoms, was noted in 367/404 (91%) patients.
Out of these 50 patients without any identifiable
precipitant on admission, 49 (98%) had an improvement
in HE on discharge. 
Similarly, 191 patients (89%) with one precipitant showed
an improvement in HE while improvements were also
noted in 113 patients (93%) with 2 precipitants and 14
patients (77%) with 3 precipitating factors (p < 0.01). 
Nine (2.2%) patients died during the hospital stay, of
whom 3  had ≤ 1 precipitating factor and 6 had ≥ 2
precipitating factor (p=0.06, Table III). There was no
mortality found in patients without any precipitating
factor. There was no significant association between the
number of precipitating factors and severity of cirrhosis
on the basis of CTP score (Table III).
DISCUSSION
Patients with chronic HE are known to have better long
term (5 years) survival than those who develop HE
acutely (100% vs. 70% survival).13 However, prognosis
in the latter group can be improved if the precipitating
factors are recognized early and managed accordingly.14
This study was aimed at identifying precipitating factors
in patients presenting to the centre with an acute onset
of HE, type C. 
It is the largest study on hepatic encephalopathy about
its precipitating factors and predictors from our region.
The results showed that 70% patients suffered from
hepatitis C, which is consistent with other studies,15,16
thus reiterating the significant disease burden posed by
this infection, which is on a rising trend in Pakistan.
Infection was identified as the main precipitant of HE in
upto 35% patients, with around 20% patients suffering
from SBP and 15% from urinary infection which is
previously reported in patients with cirrhosis from
Pakistan.17 Literature from developed countries however,
has not identified infections as amongst the most
common precipitating events,18 possibly due to more
awareness and better nutrition status in their patients.
Patients in local setting are usually severely malnourished
not only because of their disease but also because of
food faddism and taboos regarding their diet.19 Strict
dietary restrictions on these patients lead to anorexia
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Table II: Relationship of number of precipitants and grades of
hepatic encephalopathy with the hospital stay.
Factors Duration of hospitalization p-value
<  4 days ≥ 4 days
( n= 210) ( n=194)
Number of precipitating factor
None 40 (19%) 10 (5%)
One 115 (55%) 99 (51%) < 0.001
Two 50 (24%) 72 (37%)
Three 5 (2%) 13 (7%)
Child’s Pugh classification
A 6 (3%) 5 (3%)
B 46 (22%) 30 (15%) 0.243
C 158 (75%) 159 (82%)
Clinical grades of encephalopathy
Grade 1 36 (17%) 34 (18%)
Grade 2 106 (50%) 72 (37%) 0.009
Grade 3 56 (27%) 62 (32%)
Grade 4 12 (6%) 26 (13%)
Table III: Relationship of numbers of precipitating factors with different
parameters.
≤ 1 precipitant ≥ 2 precipitant p-value
n=264 n=140
Childs class
A 7 (3%) 4 (3%)
B 53 (20%) 23 (16%) 0.66
C 204 (77%) 113 (81%)
Grades of HE
Grade 1 49 (19%) 21 (15%)
Grade 2 127 (48%) 51 (36%) 0.025
Grade 3 68 (26%) 50 (36%)
Grade 4 20 (7%) 18 (13%)
Duration of stay
< 4 days 155 (59%) 55 (39%) < 0.01
≥ 4 days 109 (41%) 85 (61%)
Outcome
Alive 261 (99%) 134 (95%) 0.06
Dead 3 (1%) 6 (5%)
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and malnutrition, and eventually lowering their immunity
and making them more susceptible to infections. In the
developing world, gastrointestinal bleeding and consti-
pation have been identified as major precipitating events
of HE.18 This is considered to be secondary to increased
ammonia production and absorption, and were noted in
13.6% patients.
Well-recognized factors, which tend to precipitate
hepatic encephalopathy in patients with underlying liver
cirrhosis, include an increased dietary protein load,
constipation, and gastrointestinal hemorrhage, which
can be classified as gut factors, and are consistent with
the hypothesis that gut-derived nitrogenous constituents
of portal venous blood contribute to HE. Some of these
are neuroactive and can traverse the blood-brain barrier,
subsequently resulting in altered brain function. The
importance of gut factors in the pathogenesis of HE is
also suggested by improvement in symptoms following
evacuation of the bowel and by dietary protein restriction.20
Any factor that increases portal-systemic shunting may
also precipitate or exacerbate HE.21 Factors other than
liver failure, such as uremia, hypoglycemia, and use of
sedative or hypnotic drugs, may also contribute to
encephalopathy in such patients.
Electrolyte imbalances, also correlate with the severity
of the liver disease,22 was also found. It is explained by
the use of diuretics in patients who have ascites
secondary to decompensated liver disease. Therefore,
caution must be exercised and these patients need to be
followed vigilantly with frequent monitoring of serum
electrolytes to avoid any precipitation of HE.
In patients with low reserves of hepatic function, the
hepatic encephalopathy can be a chronic condition and
no precipitants can be established. The low reserve
predisposes the patient to development of spontaneous
hepatic encephalopathy, which was noted in 11.4%
patients, in whom no precipitating factors could be
identified. Interestingly the improvement in HE in this
group of patients without any precipitant was best as
compared to those with the precipitant induced HE.  
This study identified a longer hospital stay in patients
with ≥ 2 precipitating factor, and in those who presented
with grades 3 or 4 HE. Two-thirds of our patients who
died during the hospital stay had ≥ 2 precipitating
factors, while patients with no identifiable precipitating
event had no mortalities during their hospital stay.
Similarly, patients with ≥ 2 precipitant were mostly
suffering from grade 3 and 4 HE on initial presentation
and have a prolonged hospital stay. In a study by
Strauss et al.9 higher mortality rates were noted in acute
HE, associated with grades 3 and 4 of HE and more
precipitating factors. This indicates that patients with
increased number of precipitants tend to have a worse
outcome in terms of both duration of hospital stay and
mortality. Moreover, the improvement in HE was better in
patients with less number of precipitants and early
grades of HE. 
It is, therefore, crucial that precipitating factors are
identified earlier, especially in patients with severe liver
disease, and appropriate treatment initiated soon, with
an aim to treat and manage them, and subsequently
ensuring better outcomes. It is also important to educate
the patients and their families about these precipitants to
ensure earlier presentation, diagnosis, and management
of acute HE.
CONCLUSION
Precipitant-induced hepatic encephalopathy is a
common complication of cirrhosis. Infections, constipation
and gastrointestinal bleeding were identified as the
major precipitants in this study. Once the precipitating
condition is resolved the encephalopathy also typically
disappears, with the patient recovering to his or her
previous state. Patients with ≥ 2 precipitating factors and
grades 3 or 4 HE on admission was associated with
worse outcomes.
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